Press Releases
Investor Resources
Press Releases
Press Release
Cardiol Therapeutics Appoints Thought Leaders in Cardiovascular Medicine to its Scientific Advisory BoardJanuary 19, 2022
Press Release
Cardiol Therapeutics Announces Closing of US$50 Million Public OfferingNovember 5, 2021
Press Release
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of UnitsNovember 2, 2021
Press Release
Cardiol Therapeutics Receives Health Canada Approval for Phase II Clinical Trial of CardiolRx™ for Acute MyocarditisOctober 25, 2021
Press Release
Cardiol Therapeutics Expands LANCER, a Phase II/III Trial of CardiolRx™, into Brazil, Mexico, and CanadaOctober 18, 2021
Press Release
Cardiol Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare ConferenceSeptember 16, 2021
Press Release
Cardiol Therapeutics Announces Acceleration of Expiry Date of Warrants issued on June 4, 2020September 10, 2021